2026-05-06T02:12:26Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/193622024-09-27T08:16:50Zcom_20.500.12105_19604com_20.500.12105_2051col_20.500.12105_19605

00925njm 22002777a 4500 dc Salloum, Fadi N author Tocchetti, Carlo G author Ameri, Pietro author Ardehali, Hossein author Asnani, Aarti author de Boer, Rudolf A author Burridge, Paul author Cabrera, José-Ángel author de Castro, Javier author Córdoba, Raúl author Costa, Ambra author Dent, Susan author Engelbertsen, Daniel author Fernández-Velasco, María author Fradley, Mike author Fuster, José J author Galán-Arriola, Carlos author García-Lunar, Inés author Ghigo, Alessandra author González-Neira, Anna author Hirsch, Emilio author Ibáñez, Borja author Kitsis, Richard N author Konety, Suma author Lyon, Alexander R author Martin, Pilar author Mauro, Adolfo G author Mazo Vega, Manuel M author Meijers, Wouter C author Neilan, Tomas G author Rassaf, Tienush author Ricke-Hoch, Melanie author Sepulveda, Pilar author Thavendiranathan, Paaladinesh author van der Meer, Peter author Fuster, Valentin author Ky, Bonnie author López-Fernández, Teresa author 2023-12 Despite improvements in cancer survival, cancer therapy-related cardiovascular toxicity has risen to become a prominent clinical challenge. This has led to the growth of the burgeoning field of cardio-oncology, which aims to advance the cardiovascular health of cancer patients and survivors, through actionable and translatable science. In these Global Cardio-Oncology Symposium 2023 scientific symposium proceedings, we present a focused review on the mechanisms that contribute to common cardiovascular toxicities discussed at this meeting, the ongoing international collaborative efforts to improve patient outcomes, and the bidirectional challenges of translating basic research to clinical care. We acknowledge that there are many additional therapies that are of significance but were not topics of discussion at this symposium. We hope that through this symposium-based review we can highlight the knowledge gaps and clinical priorities to inform the design of future studies that aim to prevent and mitigate cardiovascular disease in cancer patients and survivors. JACC CardioOncol. 2023 Sep 27;5(6):715-731. 10.1016/j.jaccao.2023.08.003 2666-0873 JACC. CardioOncology 38205010 http://hdl.handle.net/20.500.12105/19362 Priorities in Cardio-Oncology Basic and Translational Science: GCOS 2023 Symposium Proceedings: JACC: CardioOncology State-of-the-Art Review.